Data / Form D filings / Calimmune, Inc.
Calimmune, Inc.: Form D filing
Calimmune, Inc., a biotechnology company in Tucson, AZ, filed a Form D with the SEC in 2015. The latest, on May 28, 2015, reports $15.9 million sold of a $16 million offering to 51 investors.
Find out what Calimmune, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5151 E. BROADWAY BLVD., SUITE 1020, Tucson, AZ, 85711
- Phone
- (310) 806-6240
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1643405
The full lists. Form D filings in Arizona: 953 rows, $47.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 28, 2015 | New notice | $15,988,448 | $15,851,969 | $136,479 | 51 | May 12, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peter Kolchinsky | Director | |
| Jon Faiz A. Kayyem, Ph.D. | Director | |
| Louis Breton | Executive Officer, Director | |
| David Baltimore, Ph.D. | Director | |
| Harry A. George | Director | |
| Bhavin H. Raval | Executive Officer | |
| David H. Donabedian, Ph.D. | Director |
Other biotechnology companies in Arizona that filed recently
- Gut-Brain-Axis Therapeutics Inc. $2 million · Oct 27, 2026
- Avery Therapeutics, Inc. $8.5 million · Sep 21, 2026
Every Form D from the week of May 25, 2015 · All recent filings in Arizona · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Calimmune, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.